Table 3 Grouping and experimental treatments

From: Application of HepG2-derived organoid and organ-on-a-chip platforms in elucidating selenium-mediated protection against cadmium-induced liver dysfunction

Group ID

Group name

  

Treatment for different groups

  

VitC

Cd30

Cd40

Cd50

t-BHP

Se40

Se160

Se640

Group 1

CK

-

-

-

-

-

-

-

-

Group 2

VitC

+

-

-

-

-

-

-

-

Group 3

Cd30

-

+

-

-

-

-

-

-

Group 4

Cd40

-

-

+

-

-

-

-

-

Group 5

Cd50

-

-

-

+

-

-

-

-

Group 6

VitC+Cd40

+

-

+

-

-

-

-

-

Group 7

t-BHP

-

-

-

+

-

-

-

-

Group 8

VitC + t-BHP

+

-

-

-

+

-

-

-

Group 9

Se40 + Cd40

-

-

+

-

-

+

-

-

Group 10

Se160 + Cd40

-

-

+

-

-

-

+

-

Group 11

Se640 + Cd40

-

-

+

-

-

-

-

+

Group 12

Se640 + t-BHP

-

-

-

-

+

-

-

+

Back to article page